Although these studies revealed activation of members of both canonical and noncanonical NF-κB pathways in acute T-cell leukemia, only inhibition of canonical NF-κB signaling was shown to impair leukemic T cell growth. The gene discussed is NFKB1; the disease is T-cell acute lymphoblastic leukemia.